Alpha Cognition Inc

Opaleye Management’s fresh buy of 2.3 M shares in Alpha Cognition signals bullish confidence, boosting R&D, reducing dilution and hinting at a rebound in the health‑tech stock.

Opaleye Management’s new 2.125‑million‑share stake in Alpha Cognition signals bullish confidence, highlighting the company’s patent‑driven upside potential for investors.

Alpha Cognition’s insider buying surge signals confidence, with executives boosting holdings amid new patent filings and potential upside for investors.

Insider buying at Alpha Cognition signals management’s confidence as they buy shares and options, hinting at a possible rebound amid valuation pressures.

Alpha Cognition insiders buy zero‑cost shares and options, showing quiet confidence amid a 12% weekly dip—watch for future growth catalysts.